Agemica

more life

[Agemica @AgemicaCom]

Introducing Agemica.

On our mission to solve aging.

[Agemica @AgemicaCom]

Excited to announce that Agemica won the Innovation Excellence Award at RGMBS 2026 in Riyadh!

https://t.co/0QgaCwiWXR

100+ companies applied to the Life Sciences Innovation Forum, 23 companies from 8 countries pitched, and just 5 awards were presented.

Agemica was recognized for our work on next-generation aging and pan-cancer vaccines.

Our ambition: harness AI, immunology and vaccine technology to tackle two of humanity’s biggest challenges: aging and cancer.

Proud of the Agemica team, and excited to build the next stage.

[Agemica @AgemicaCom]

@MCGlive @RonjonNag @MiyaHedge @StreetFDN Thanks for having us!

[Agemica @AgemicaCom]

Thanks a lot to @andyfolio for this great video and everyone who helped coming together to shoot this!

The next (live) video will be even more awesome.

[Agemica @AgemicaCom]

Thanks for all the positive reception on our launch video!

Over 1M views in < 24h.

We started Agemica with an ambition that is deeply personal: more healthy years. More time to build things, explore the world, and spend with the people we love.

We’re using frontier AI models to advance drug discovery because we believe there is an enormous opportunity to change how we approach aging and disease.

We also made a deliberate decision about the company we want to build: give more people a meaningful way to participate in it. That is why we launched $AGE.

The token has two functions.

Through @StreetFDN 's SPV-backed structure, $AGE provides eligible holders with economic exposure linked to a allocation initially calculated at 10% of Agemica’s fully diluted capitalization at launch. That allocation is subject to dilution, performance conditions and repurchase rights.

Holding $AGE also earns points that improve a holder’s position on Agemica’s product waitlist, increasing their priority as products become available.

We chose this structure to give people who share our interest in longevity a defined connection to Agemica: economic participation and product priority.

Over time, we want to build a community that follows the research, understands the decisions behind it, and contributes to the company’s development.
$AGE is a long term part and strategy of that approach.

Our focus remains on advancing the science and building Agemica for the long term.

More life.

[Agemica @AgemicaCom]

Introducing Agemica.

On our mission to solve aging.

[Ronjon Nag OBE @RonjonNag]

Really fantastic to work StreetFDN with innovative ways to grow deep science moonshots

[Agemica @AgemicaCom]

@andyfolio Thanks for the great video!

[Street @StreetFDN]

Excited to work together with @AgemicaCom on their mission to solve aging.

[Agemica @AgemicaCom]

You deserve more than 80 years of life.

We're here to bring this life to you.

https://t.co/RSmihefW9J

[Agemica @AgemicaCom]

Introducing Agemica.

On our mission to solve aging.

[Agemica @AgemicaCom]

Dr. Jayakumar Rajadas. Scientific advisor.

Three decades developing drugs.

260+ publications.
82+ patents.

Founded Stanford’s Advanced Drug Delivery and Regenerative Biomaterials Laboratory.

Bringing the experience needed to help discoveries become medicines.